Richard E Clark

9PUBLICATIONS
30CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)HaematologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross

|Jan 07, 2022
The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

Paolo Gallipoli, Richard E Clark, Jenny Byrne

|Oct 01, 2021
Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients.

Mike Dennis, Ian F Thomas, Cono Ariti

|Jun 10, 2021
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.

Hagop M Kantarjian, Timothy P Hughes, Richard A Larson

|Jan 08, 2021
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.

Hagop M Kantarjian, Timothy P Hughes, Richard A Larson

|Dec 28, 2020
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses.

Alan K Burnett, Nigel H Russell, Robert K Hills

Pageof 2

Frequent Collaborators

3 joint publications

Hagop M Kantarjian

3 joint publications

Richard A Larson

3 joint publications

Dong-Wook Kim

1 joint publications

Nigel H Russell